VEGFA and coronary artery disorder: While a relative insufficiency of circulating VEGF in these conditions has prompted a series of clinical trials attempting to exploit the angiogenic properties of VEGF in patients with chronic coronary artery disease (CAD), these have, to date, been disappointing [40–42], although clinical investigation in this area continues [43].